Xcout Intel
SpotItEarly
SpotitEarly, Inc. is a biotechnology company incorporated in Delaware that develops biological detection solutions for medical and diagnostic screening.
Subscribe to see SpotItEarly’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
SpotItEarly at a glance
SpotItEarly is an early detection technologies company headquartered in United States. It has raised at least $26M across the 3 funding rounds on record. Its most recent funding round raised $10,000 in July 2025. Xcout tracks 15 named people at SpotItEarly, including Shlomi Madar (CEO).
SpotItEarly leadership
- Shlomi MadarCEO
- Ariel Ben DayanFounder
- Ohad SharonFounder
- Roi OphirFounder
- Udi BobrovskyFounder
- Assaf Leonard RufExecutive Officer
9 more named people on record for SpotItEarly, with roles, board committees and tenure — see the full roster →
SpotItEarly funding rounds
At least $26M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10,000 | — | |
| Series U | $20.3M | 14 named | |
| Seed | $6.2M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
SpotItEarly competitors
A few of SpotItEarly's closest competitors — see the full list of competitors and alternatives →
Epicore Biosystems, Inc. is a Delaware corporation specializing in wearable health technology and microfluidic biosensing systems. The company scales its digital health platform applications, as evidenced by a $26 million Series B funding round. It delivers innovative physiological monitoring products for consumers and researchers.
Syndicate Bio is a biotechnology company headquartered in Delaware that accelerates precision medicine initiatives with a launch rooted out of Nigeria. The company focuses on advancing genomic research and healthcare solutions tailored for diverse populations.
Sense Photonics, Inc. is a technology startup that invents advanced detection mapping and LiDAR solutions. Initially emerging from stealth mode with venture backing, the Delaware-incorporated corporation operates research and development facilities within Research Triangle Park.
General Sense is a biotechnology and analytics company founded in 2020 that captures real-time molecular data at high sensitivities. Formerly known as Canaery, the company operates with a small team and maintains a presence in Florida and Pennsylvania.
Sarmal, Inc. is a San Diego-based biotechnology company founded in 2003 that develops next-generation genomic sequencing platforms, whole-genome sequencing technology, and field-deployable nucleic acid diagnostics. The company focuses on innovations in advanced nucleic acid sequencing and target sequence detection.
Get SpotItEarly's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on SpotItEarly in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access